Related Experiment Video
Updated: Jul 6, 2026

Leprdb Mouse Model of Type 2 Diabetes: Pancreatic Islet Isolation and Live-cell 2-Photon Imaging Of Intact Islets
Published on: May 11, 2015
Microparticles and type 2 diabetes
A S Leroyer1, A Tedgui, C M Boulanger
1Institut National de la Santé et de la Recherche Médicale, Inserm unit 689, Cardiovascular Research Center Inserm Lariboisière, 41, bd de la Chapelle, 75475 Paris cedex 10, France.
Abstract:
Cell activation or apoptosis leads to plasma membrane blebbing and microparticles (MPs) release in the extracellular space. MPs are submicron membrane vesicles, which harbour a panel of oxidized phospholipids and proteins specific to the cells they derived from. MPs are found in the circulating blood of healthy volunteers. MPs levels are increased in many diseases, including cardiovascular diseases with high thrombotic risk. Exposure of negatively charged phospholipids and tissue factor confers a procoagulant potential to MPs. Elevation of plasma MPs levels, particularly those of endothelial origin, reflects cellular injury and appears now as a surrogate marker of vascular dysfunction. Recent studies demonstrate an elevation of circulating levels of MPs in diabetes. MPs could also be involved in the development of vascular complications in diabetes for they stimulate pro-inflammatory responses in target cells and promote thrombosis, endothelial dysfunction and angiogenesis. Thus, these studies provide new insight in the pathogenesis and treatment of vascular complications of diabetes.
Insights
Microparticles (MPs), released from activated cells, are elevated in diabetes and cardiovascular diseases. These procoagulant vesicles may drive vascular complications through inflammation and thrombosis.
Area of Science:
- Cardiovascular Biology
- Endocrinology
- Cell Biology
Background:
- Cell activation or apoptosis releases microparticles (MPs), which are extracellular vesicles containing cell-specific oxidized phospholipids and proteins.
- MPs are present in healthy blood but elevated in diseases like cardiovascular disease, reflecting cellular injury and vascular dysfunction.
- Elevated MPs, especially from endothelial cells, serve as a marker for vascular dysfunction.
Purpose of the Study:
- To investigate the role of microparticles in the pathogenesis of vascular complications in diabetes.
- To explore how MPs contribute to inflammation, thrombosis, endothelial dysfunction, and angiogenesis in diabetic vascular disease.
Main Methods:
- Analysis of circulating microparticle levels in healthy individuals and patients with diabetes.
- Characterization of the molecular cargo (phospholipids, proteins) of microparticles.
- In vitro studies assessing the effects of MPs on target cells, including pro-inflammatory responses, thrombosis, endothelial function, and angiogenesis.
Main Results:
- Circulating microparticle levels are elevated in individuals with diabetes.
- MPs possess procoagulant properties due to exposed phospholipids and tissue factor.
- MPs stimulate pro-inflammatory responses, promote thrombosis, endothelial dysfunction, and angiogenesis in target cells.
Conclusions:
- Elevated microparticle levels are associated with diabetes and may indicate vascular dysfunction.
- Microparticles play a significant role in the development of vascular complications in diabetes.
- MPs represent a potential therapeutic target for managing diabetic vascular disease.
Related Concept Videos
Type II Diabetes II: Pathophysiology
Type II Diabetes I: Introduction
Type I Diabetes II: Pathophysiology
Diabetes Mellitus: Type 2 and Gestational
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis